Antithrombotic therapy for patients with atrial fibrillation project protocol
The objective of the systematic review is to compare the clinical and cost-effectiveness of oral antithrombotic agents (i.e., anticoagulant and antiplatelet agents) for the prevention of stroke and other thromboembolic events in patients with atrial fibrillation
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
August 2012, 2012
|
| Series: | CADTH therapeutic review
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The objective of the systematic review is to compare the clinical and cost-effectiveness of oral antithrombotic agents (i.e., anticoagulant and antiplatelet agents) for the prevention of stroke and other thromboembolic events in patients with atrial fibrillation |
|---|---|
| Physical Description: | 1 PDF file (4 pages) |